AnalystsMaury RaycroftMaury Raycroft's Stock Forecasts
AnalystsMaury Raycroft
Sectors:
Industries:
Analyst Ranking
Bottom 4%
#5321 out of 5523 analysts
Average Return
-15.05%
Win Rate
25%15 out of 60
Risk vs Reward
Poor
Good
Maury Raycroft's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Reata Pharmaceuticals IncRETA | +198.41% | $28.93 | $86.33 | 2017-08-30 - 2018-08-30 | Strong Buy |
Arrowhead Pharmaceuticals IncARWR | +157.02% | $6.91 | $17.76 | 2018-03-27 - 2019-03-27 | Strong Buy |
Kodiak Sciences IncKOD | +115.99% | $15.01 | $32.42 | 2025-09-22 - 2026-09-21 | Strong Buy |
Dianthus Therapeutics IncDNTH | +99.13% | $11.50 | $22.90 | 2023-12-26 - 2024-12-24 | Strong Buy |
Tyra Biosciences IncTYRA | +88.64% | $15.40 | $29.05 | 2021-10-11 - 2021-11-08 | Strong Buy |
Maury Raycroft Analyst Color
Get additional color on Maury Raycroft's coverage of popular stocks
Maury Raycroft's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Q32 Bio IncQTTB | 1 | Strong Buy | $29.00 | +214.19% | Initiates Coverage On | a day ago |
Adlai Nortye Group LtdANL | 1 | Strong Buy | $31.00 | +101.30% | Initiates Coverage On | 20 days ago |
Ultragenyx Pharmaceutical IncRARE | 2 | Strong Buy | $28.00 | +94.31% | Maintains | a month ago |
Hemab Therapeutics Holdings IncCOAG | 2 | Strong Buy | $47.00 | +41.91% | Maintains | 3 months ago |
Tango Therapeutics IncTNGX | 3 | Strong Buy | $60.00 | +146.91% | Upgrades | 3 months ago |
Corbus Pharmaceuticals Holdings IncCRBP | 3 | Strong Buy | $33.00 | +376.88% | Maintains | 5 months ago |
Tyra Biosciences IncTYRA | 4 | Strong Buy | $43.00 | +100.47% | Maintains | 8 months ago |
Dianthus Therapeutics IncDNTH | 3 | Strong Buy | $81.00 | -7.78% | Maintains | 8 months ago |
Mereo Biopharma Group PLCMREO | 2 | Hold | $0.50 | +35.14% | Downgrades | 9 months ago |
Celcuity IncCELC | 2 | Strong Buy | $134.00 | +68.26% | Maintains | 10 months ago |
Aurinia Pharmaceuticals IncAUPH | 1 | Strong Buy | $21.00 | +27.12% | Upgrades | a year ago |
Opko Health IncOPK | 1 | Hold | $1.60 | -1.84% | Downgrades | a year ago |
Alnylam Pharmaceuticals IncALNY | 4 | Strong Buy | $549.00 | +114.99% | Maintains | a year ago |
Kezar Life Sciences IncKZR | 2 | Hold | $7.00 | -3.98% | Downgrades | a year ago |
Kodiak Sciences IncKOD | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | a year ago |
Cardiff Oncology IncCRDF | 1 | Hold | $3.50 | N/A | Initiates Coverage On | a year ago |
Chimerix IncCMRX | 2 | Hold | $8.50 | N/A | Downgrades | 2 years ago |
Compass Therapeutics IncCMPX | 2 | Strong Buy | $8.00 | N/A | Maintains | 2 years ago |
Sangamo Therapeutics IncSGMO | 1 | Strong Buy | $3.00 | N/A | Maintains | 2 years ago |
Erasca IncERAS | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | 2 years ago |
Inozyme Pharma IncINZY | 1 | Strong Buy | $17.00 | N/A | Assumes | 2 years ago |
Calliditas Therapeutics AbCALT | 2 | Hold | $39.00 | N/A | Downgrades | 2 years ago |
Prime Medicine IncPRME | 1 | Strong Buy | $15.00 | N/A | Assumes | 2 years ago |
Cue Biopharma IncCUE | 1 | Strong Buy | $180.00 | N/A | Initiates Coverage On | 3 years ago |
Metagenomi Therapeutics IncMGX | 1 | Strong Buy | $23.00 | N/A | Initiates Coverage On | 3 years ago |
Tempest Therapeutics IncTPST | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | 3 years ago |
Mirati Therapeutics IncMRTX | 2 | Hold | $58.00 | N/A | Downgrades | 3 years ago |
Biocryst Pharmaceuticals IncBCRX | 3 | Strong Buy | $11.00 | N/A | Upgrades | 3 years ago |
Reata Pharmaceuticals IncRETA | 2 | Hold | $172.50 | N/A | Downgrades | 3 years ago |
Spectrum Pharmaceuticals IncSPPI | 1 | Hold | $1.50 | N/A | Downgrades | 3 years ago |
Allakos IncALLK | 2 | Strong Buy | $9.00 | N/A | Upgrades | 3 years ago |
Vera Therapeutics IncVERA | 2 | Hold | $6.00 | N/A | Downgrades | 4 years ago |
Arrowhead Pharmaceuticals IncARWR | 2 | Strong Buy | $75.00 | N/A | Maintains | 4 years ago |
Imago Biosciences IncIMGO | 2 | Hold | $36.00 | N/A | Downgrades | 4 years ago |
Rezolute IncRZLT | 1 | Strong Buy | $11.00 | N/A | Initiates Coverage On | 4 years ago |
Forma Therapeutics Holdings IncFMTX | 1 | Hold | $20.00 | N/A | Downgrades | 4 years ago |
Sierra Oncology IncSRRA | 1 | Hold | $55.00 | N/A | Downgrades | 4 years ago |
Beyondspring IncBYSI | 2 | Hold | $5.00 | N/A | Downgrades | 5 years ago |
Ayala Pharmaceuticals IncAYLA | 1 | Strong Buy | $17.00 | N/A | Upgrades | 5 years ago |
Theseus Pharmaceuticals IncTHRX | 1 | Strong Buy | $23.00 | N/A | Initiates Coverage On | 5 years ago |
Aslan Pharmaceuticals LtdASLN | 1 | Strong Buy | $320.00 | N/A | Initiates Coverage On | 5 years ago |
Valneva SeVALN | 1 | Strong Buy | $36.00 | N/A | Initiates Coverage On | 5 years ago |
Solid Biosciences IncSLDB | 1 | Strong Buy | $105.00 | N/A | Initiates Coverage On | 5 years ago |
Crispr Therapeutics AgCRSP | 1 | Strong Buy | $172.00 | N/A | Upgrades | 5 years ago |
Checkmate Pharmaceuticals IncCMPI | 1 | Strong Buy | $22.00 | N/A | Initiates Coverage On | 6 years ago |
Black Diamond Therapeutics IncBDTX | 1 | Strong Buy | $47.00 | N/A | Initiates Coverage On | 7 years ago |
Affimed NvAFMDQ | 5 | Strong Buy | $40.00 | N/A | Upgrades | 8 years ago |
Intellia Therapeutics IncNTLA | 1 | Strong Buy | $42.00 | N/A | Maintains | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.